.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Fish and Richardson
Chubb
Argus Health
Citi
Harvard Business School
Deloitte
Express Scripts
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

Indomethacin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indomethacin and what is the scope of indomethacin patent protection?

Indomethacin
is the generic ingredient in six branded drugs marketed by Sun Pharm Inds, Sun Pharm Inds Inc, Zydus Pharms Usa Inc, Jubilant Generics, Parke Davis, Hetero Labs Ltd Iii, Inwood Labs, Cycle Pharms Ltd, Pioneer Pharms, Able, Iroko Pharms, G And W Labs, Ivax Sub Teva Pharms, Mylan, Duramed Pharms Barr, Paddock Llc, Chartwell Molecules, Watson Labs, Halsey, Fresenius Kabi Usa, Mylan Pharms Inc, Teva, Aurobindo Pharma Ltd, Pliva, Amneal Pharms, Heritage Pharms Inc, Novast Labs Ltd, Iroko Pharms Llc, Sandoz, Mutual Pharm, Watson Labs Inc, Avanthi Inc, Glenmark Generics, Superpharm, West-ward Pharms Int, Hospira Inc, and Recordati Rare, and is included in sixty-six NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Indomethacin has thirty-two patent family members in eighteen countries.

There are fifteen drug master file entries for indomethacin. Fifty-two suppliers are listed for this compound.

Summary for Generic Name: indomethacin

Tradenames:6
Patents:4
Applicants:37
NDAs:66
Drug Master File Entries: see list15
Suppliers / Packagers: see list52
Bulk Api Vendors: see list99
Clinical Trials: see list116
Patent Applications: see list9,064
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:indomethacin at DailyMed

Pharmacology for Ingredient: indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
INDO-LEMMON
indomethacin
CAPSULE;ORAL070266-001Nov 7, 1985DISCNNoNo► Subscribe► Subscribe
Recordati Rare
INDOCIN
indomethacin sodium
INJECTABLE;INJECTION018878-001Jan 30, 1985APRXYesYes► Subscribe► Subscribe
Hospira Inc
INDOMETHACIN SODIUM
indomethacin sodium
INJECTABLE;INJECTION204118-001Apr 19, 2016APRXNoNo► Subscribe► Subscribe
Able
INDOMETHACIN
indomethacin
CAPSULE;ORAL076666-002Dec 17, 2003DISCNNoNo► Subscribe► Subscribe
Watson Labs
INDOMETHACIN
indomethacin
CAPSULE;ORAL071635-001May 18, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 19843,644,630► Subscribe
Iroko Pharms
INDOCIN SR
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL018185-001Feb 23, 19824,173,626► Subscribe
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 19843,849,549► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: indomethacin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,095,496Formulation of indomethacin► Subscribe
9,522,135Formulation of indomethacin► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: indomethacin

Country Document Number Estimated Expiration
New Zealand595986► Subscribe
European Patent Office2421513► Subscribe
Japan2012524724► Subscribe
South Africa201108646► Subscribe
New Zealand620879► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
McKinsey
Dow
Johnson and Johnson
Deloitte
Merck
Boehringer Ingelheim
Covington
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot